Angiotensin II receptor density was significantly lower in Cushing's adenomas compared to controls (27.6 vs 59.3 fmol/mg; P<0.05), and nearly undetectable in pheochromocytomas and adrenal carcinomas.
Observational
Angiotensin II receptors are normally expressed in aldosterone-producing adenomas but have reduced density in Cushing's adenomas and are nearly undetectable in pheochromocytomas and adrenal carcinomas, suggesting a link between receptor reduction and tumor dedifferentiation or malignancy.
p-value: p=<0.05
Several pieces of evidences suggest that angiotensin II (Ang II) has mitogenic effects, and a link between Ang II receptors and adrenal tumors can be suggested. In various adrenal tumors, aldosterone-producing adenoma (APA), Cushing's adrenal adenomas (Cush), pheochromocytomas (Pheo), and adrenal carcinomas, we studied the density, affinity, and subtype of Ang II receptors. Ang II binding was tested in cell membrane homogenates. 125IAng II was used as ligand, and Losartan and CGP 42112 were used as selective Ang II type 1 and type 2 antagonists, respectively. In APA, Ang II receptor density was 178.5 +/- 82.7 fmol/mg: however, due to the high degree of variability, the receptor density was not significantly higher than that in nontumorous adrenal cortex (59.3 +/- 8.4 fmol/mg). In Cush, the receptor density (27.6 +/- 8.2 fmol/mg; P < 0.05) was significantly lower than that in controls, whereas in Pheo and cortical carcinoma, Ang II binding was very low and in several cases almost undetectable. There was no remarkable difference in the Ang II receptor affinity among all tissues tested. The ratio between type 1 and type 2 Ang II receptors showed a large prevalence of type 1 in controls, APA, and three cases of Cush; in two cases of Cush, this ratio was reversed. In conclusion, our data indicate that Ang II receptors are normally expressed in APA and can also be detected in Cush, whereas they have a very low density in Pheo and adrenal carcinoma. Therefore, Ang II receptors are not involved in the lack of response to Ang II that is characteristic of APA; additionally, a reduction of Ang II receptors can be associated with dedifferentiation or malignancy of adrenal tumors. Further investigation of the expression and functional characterization of Ang II receptors is required to better clarify their possible role in adrenal tumorigenesis.
Opocher et al. (Sat,) conducted a observational in Adrenal tumors. Adrenal tumors vs. Nontumorous adrenal cortex was evaluated on Angiotensin II receptor density (p=<0.05). Angiotensin II receptor density was significantly lower in Cushing's adenomas compared to controls (27.6 vs 59.3 fmol/mg; P<0.05), and nearly undetectable in pheochromocytomas and adrenal carcinomas.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: